TY - JOUR
T1 - Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization
AU - Yang, Xiuwei H.
AU - Kovalenko, Oleg V.
AU - Kolesnikova, Tatiana V.
AU - Andzelm, Milena M.
AU - Rubinstein, Eric
AU - Strominger, Jack L.
AU - Hemler, Martin E.
PY - 2006/5/5
Y1 - 2006/5/5
N2 - CD9, a tetraspanin protein, makes crucial contributions to sperm egg fusion, other cellular fusions, epidermal growth factor receptor signaling, cell motility, and tumor suppression. Here we characterize a low affinity anti-CD9 antibody, C9BB, which binds preferentially to homoclustered CD9. Using mAb C9BB as a tool, we show that cell surface CD9 homoclustering is promoted by expression of α3β1 and α6β4 integrins and by palmitoylation of the CD9 and β4 proteins. Conversely, CD9 is shifted toward heteroclusters upon expression of CD9 partner proteins (EWI-2 and EWI-F) or other tetraspanins, or upon ablation of CD9 palmitoylation. Furthermore, unpalmitoylated CD9 showed enhanced EWI-2 association, thereby demonstrating a previously unappreciated role for tetraspanin palmitoylation, and underscoring how depalmitoylation and EWI-2 association may collaborate to shift CD9 from homo- to heteroclusters. In conclusion, we have used a novel molecular probe (mAb C9BB) to demonstrate the existence of multiple types of CD9 complex on the cell surface. A shift from homo- to heteroclustered CD9 may be functionally significant because the latter was especially obvious on malignant epithelial tumor cells. Hence, because of its specialized properties, C9BB may be more useful than other anti-CD9 antibodies for monitoring CD9 during tumor progression.
AB - CD9, a tetraspanin protein, makes crucial contributions to sperm egg fusion, other cellular fusions, epidermal growth factor receptor signaling, cell motility, and tumor suppression. Here we characterize a low affinity anti-CD9 antibody, C9BB, which binds preferentially to homoclustered CD9. Using mAb C9BB as a tool, we show that cell surface CD9 homoclustering is promoted by expression of α3β1 and α6β4 integrins and by palmitoylation of the CD9 and β4 proteins. Conversely, CD9 is shifted toward heteroclusters upon expression of CD9 partner proteins (EWI-2 and EWI-F) or other tetraspanins, or upon ablation of CD9 palmitoylation. Furthermore, unpalmitoylated CD9 showed enhanced EWI-2 association, thereby demonstrating a previously unappreciated role for tetraspanin palmitoylation, and underscoring how depalmitoylation and EWI-2 association may collaborate to shift CD9 from homo- to heteroclusters. In conclusion, we have used a novel molecular probe (mAb C9BB) to demonstrate the existence of multiple types of CD9 complex on the cell surface. A shift from homo- to heteroclustered CD9 may be functionally significant because the latter was especially obvious on malignant epithelial tumor cells. Hence, because of its specialized properties, C9BB may be more useful than other anti-CD9 antibodies for monitoring CD9 during tumor progression.
UR - http://www.scopus.com/inward/record.url?scp=33744949738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744949738&partnerID=8YFLogxK
U2 - 10.1074/jbc.M510617200
DO - 10.1074/jbc.M510617200
M3 - Article
C2 - 16537545
AN - SCOPUS:33744949738
SN - 0021-9258
VL - 281
SP - 12976
EP - 12985
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 18
ER -